TYZEKA Side Effects

6614090-9 | Blood Creatine Phosphokinase Increased, Gingival Bleeding, Lipids Increased, Myalgia, Rhabdomyolysis
on Feb 23, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with hepatitis b (What is hepatitis b?), lipids increased and was treated with Tyzeka (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, gingival bleeding, lipids increased, myalgia, rhabdomyolysis. Tyzeka dosage: 600 Mg, Qw4. During the same period patient was treated with LIPITOR (5 Mg, Qd) (View Lipitor Review and Lipitor Label ), LOPID (600 Mg, Bid) (View Lopid Review and Lopid Label ), METOPROLOL TARTRATE (1000 Mg, Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5988679-4 | Cardiomyopathy, Echocardiogram Abnormal, Left Ventricular Dysfunction
Patient was taking Tyzeka (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), echocardiogram abnormal, left ventricular dysfunction on Dec 01, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 171.0 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Tyzeka dosage: 600 Mg, After Every Other Dialysis.

5816060-7 | Burning Sensation, Hypoaesthesia, Muscle Spasms, Neuropathy Peripheral, Pain, Paraesthesia, Vibration Test Abnormal
Adverse event was reported on Jul 11, 2008 by a Female patient taking Tyzeka (View Usage) (Dosage: 600 Mg, Qd) was diagnosed with hepatitis b virus test and. Location: UNITED KINGDOM , weighting 97.89 lb, After Tyzeka was administered, patient had the following side effects: burning sensation, hypoaesthesia, muscle spasms, neuropathy peripheral, pain (What is pain?), paraesthesia, vibration test abnormal. During the same period patient was treated with COMPARATOR PEGASYS (180 Mcg Weekly) (View Comparator Pegasys Review and Comparator Pegasys Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), SENNA (Unk) (View Senna Review and Senna Label ), FYBOGEL (View Fybogel Review and Fybogel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

5809492-4 | Carpal Tunnel Syndrome, Hypoaesthesia, Myalgia, Peripheral Sensory Neuropathy, Radiculopathy
on Jul 04, 2008 Male patient from TAIWAN, PROVINCE OF CHINA , weighting 160.9 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). Patient experienced the following unwanted or unexpected effects: carpal tunnel syndrome (What is carpal tunnel syndrome?), hypoaesthesia, myalgia, peripheral sensory neuropathy, radiculopathy. Tyzeka dosage: 600 Mg,. During the same period patient was treated with COMPARATOR PEGASYS (180 Ug,) (View Comparator Pegasys Review and Comparator Pegasys Label ).


5802675-9 | Hypoaesthesia, Radiculopathy
on Jul 04, 2008 Male patient from SINGAPORE , weighting 118.4 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). Patient had the following side effects: hypoaesthesia, radiculopathy. Tyzeka dosage: 600 Mg, Unk.

5801609-0 | Polyneuropathy
Patient was taking Tyzeka (View Usage). After Tyzeka was administered, patient had the following side effects: polyneuropathy on Jun 25, 2008 from ISRAEL Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Tyzeka dosage: 600 Mg,.

5795850-3 | Angiopathy, Hypoaesthesia
Adverse event was reported on Jun 19, 2008 by a Male patient taking Tyzeka (View Usage) (Dosage: 600 Mg, Unk) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: SINGAPORE , weighting 118.4 lb, Patient experienced the following unwanted or unexpected effects: angiopathy, hypoaesthesia.

5792726-2 | Electromyogram Abnormal, Neuropathy Peripheral
on Mar 05, 2008 Male patient from UNITED STATES , 38 years of age, weighting 170.0 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). Patient had the following side effects: electromyogram abnormal, neuropathy peripheral. Tyzeka dosage: 600 Mg, Qd, Oral. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), CELEXA (View Celexa Review and Celexa Label ).

5765743-6 | Asthenia, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Hyperreflexia, Muscle Atrophy, Polymyositis, Weight Decreased
on Jun 06, 2008 Male patient from SINGAPORE , weighting 119.0 lb, was diagnosed with hepatitis b (What is hepatitis b?), hypertension and was treated with Tyzeka (View Usage). After Tyzeka was administered, patient had the following side effects: asthenia, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, hyperreflexia, muscle atrophy, polymyositis, weight decreased. Tyzeka dosage: 600 Mg,. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

5765721-7 | Asthenia, Pain, Paraesthesia, Peripheral Sensory Neuropathy, Sensory Loss
Patient was taking Tyzeka (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, pain (What is pain?), paraesthesia, peripheral sensory neuropathy, sensory loss on Jun 02, 2008 from ISRAEL Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Tyzeka dosage: 600 Mg,. During the same period patient was treated with PEGASYS (180 Mcg) (View Pegasys Review and Pegasys Label ). Patient was hospitalized.

5764778-7 | Caesarean Section, Normal Newborn
Adverse event was reported on Jun 03, 2008 by a Female patient taking Tyzeka (View Usage) (Dosage: 600 Mg, Unk) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , weighting 149.0 lb, Patient had the following side effects: caesarean section, normal newborn. During the same period patient was treated with TRUVADA (500 Mg, Unk) (View Truvada Review and Truvada Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5762319-1 | Blood Creatine Phosphokinase Increased, Myalgia, Myositis, Paraesthesia, Peripheral Sensory Neuropathy
on May 29, 2008 Male patient from ARGENTINA , weighting 206.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). After Tyzeka was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia, myositis (What is myositis?), paraesthesia, peripheral sensory neuropathy. Tyzeka dosage: 600 Mg, Qd. During the same period patient was treated with PEGASYS (180 Ug, Qw) (View Pegasys Review and Pegasys Label ).

5730214-X | Neuropathy Peripheral
on Feb 23, 2008 Male patient from UNITED STATES , 38 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral. Tyzeka dosage: Oral. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ).

5730183-2 | Electromyogram Abnormal, Neuropathy Peripheral
Patient was taking Tyzeka (View Usage). Patient had the following side effects: electromyogram abnormal, neuropathy peripheral on Mar 24, 2008 from UNITED STATES Additional patient health information: Male patient , 38 years of age, weighting 170.0 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Tyzeka dosage: 600 Mg, Qd, Oral. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), CELEXA (View Celexa Review and Celexa Label ).

5507843-1 | Delivery, Dyspnoea, Fatigue, Somnolence
Adverse event was reported on Aug 14, 2007 by a Female patient taking Tyzeka (View Usage) (Dosage: 600 Mg, Qd, Oral) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , 30 years of age, After Tyzeka was administered, patient had the following side effects: delivery, dyspnoea, fatigue, somnolence.

5507841-8 | Rash Maculo-papular
on Aug 27, 2007 Male patient from UNITED STATES , 48 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Tyzeka (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular. Tyzeka dosage: 600 Mg; Qd; Oral.